Lippon Pharma Private Limited, a active private limited company, was established on 04 June 2019 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909TN2019PTC129735. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.90 M.
Its leadership includes Ramalingam (Director), Komala (Director), Nazerkhan Alfin (Director). Past directors included Priyadharisini. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No:211 Cdn Nagar , Main Road Nerkundram, Chennai, Tamil Nadu, 600107.
U51909TN2019PTC129735
129735
04 June 2019
₹1.00 M
₹0.90 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Lippon Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramalingam | Director | 27 Nov 2023 | Current |
| Komala | Director | 14 May 2021 | Current |
| Nazerkhan Alfin | Director | 04 Jun 2019 | Current |
| Ramanathan Rajeshwari | Director | 04 Jun 2019 | Current |
| Venkatraman | Director | 04 Jun 2019 | Current |
| Kaliyaperumal Vadivel | Director | 04 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lippon Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 138.29% increase. The company also saw a substantial improvement in profitability, with a 138.9% increase in profit. The company's net worth Soared by an impressive increase of 170.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Lippon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Lippon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lippon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lippon Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lippon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Lippon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity Ramalingam was appointed as a Director was appointed as a Director on 27 Nov 2023 & has been associated with this company since 2 years 26 days . was completed.
The activity Komala was appointed as a Director was appointed as a Director on 14 May 2021 & has been associated with this company since 4 years 7 months . was completed.
The activity Nazerkhan Alfin was appointed as a Director was appointed as a Director on 04 Jun 2019 & has been associated with this company since 6 years 6 months . was completed.
The activity Ramanathan Rajeshwari was appointed as a Director was appointed as a Director on 04 Jun 2019 & has been associated with this company since 6 years 6 months . was completed.
The CIN of Lippon Pharma Private Limited is U51909TN2019PTC129735.
Lippon Pharma Private Limited is headquartered at No:211 Cdn Nagar , Main Road Nerkundram, Chennai, Tamil Nadu, 600107.
Lippon Pharma Private Limited was incorporated on 04 June 2019.
The current directors of Lippon Pharma Private Limited are
The primary industry of Lippon Pharma Private Limited is Trade.
Lippon Pharma Private Limited is unlisted.
The authorized capital of Lippon Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.90 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX